In Brief: Georgetown/Stanford drug development conference
Georgetown/Stanford drug development conference: Four-day training course on clinical development of new drug and biologics will be held July 8-11 at Stanford University in Palo Alto. The conference is co-sponsored by the Georgetown University Center for Drug Development Science, headed by former FDA CDER Director Carl Peck, MD...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth